LANGE LOUIS G sold 44.6% of their position (11K shares) of AUDENTES THERAPEUTICS, INC. on the open market
Open‑market sale worth $655.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/27/2019ACC: 0001209191-19-062016
-11K
Net shares
Net seller
$655.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−10K
Price / share
$59.60
Trade value
$595.99K
% of position
3.6%
12/23/2019
275.80K→265.80K
Common Stock
Indirect
Shares
−1K
Price / share
$59.60
Trade value
$59.60K
% of position
6.8%
12/23/2019
14.68K→13.68K
Total
Net shares
−11K
Net value
-$655.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2019 | S · Sale | −10K | $59.60 | $595.99K | 3.6% | 275.80K | 265.80K |
| Common Stock Indirect | 12/23/2019 | S · Sale | −1K | $59.60 | $59.60K | 6.8% | 14.68K | 13.68K |
| Total | −11K | -$655.59K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.56K
Common Stock
IndirectShares owned32.34K
Total
35.90K indirect35.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.56K | Indirect |
| Common Stock | 32.34K | Indirect |
| Total | 35.90K | 35.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported